Ernexa Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ERNA and other ETFs, options, and stocks.About ERNA
Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications.
CEOSanjeev Luther
CEOSanjeev Luther
Employees6
Employees6
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded1984
Founded1984
Employees6
Employees6
ERNA Key Statistics
Market cap10.20M
Market cap10.20M
Price-Earnings ratio-0.28
Price-Earnings ratio-0.28
Dividend yield—
Dividend yield—
Average volume50.82K
Average volume50.82K
High today$1.31
High today$1.31
Low today$1.11
Low today$1.11
Open price$1.16
Open price$1.16
Volume108.90K
Volume108.90K
52 Week high$14.40
52 Week high$14.40
52 Week low$1.09
52 Week low$1.09
Stock Snapshot
Ernexa Therapeutics(ERNA) stock is priced at $1.31, giving the company a market capitalization of 10.2M. It carries a P/E multiple of -0.28.
During the trading session on 2025-12-04, Ernexa Therapeutics(ERNA) shares reached a daily high of $1.31 and a low of $1.11. At a current price of $1.31, the stock is +18.0% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 108.9K, compared to an average daily volume of 50.82K.
Over the past 52 weeks, Ernexa Therapeutics(ERNA) stock has traded between a high of $14.40 and a low of $1.09.
Over the past 52 weeks, Ernexa Therapeutics(ERNA) stock has traded between a high of $14.40 and a low of $1.09.
People also own
Based on the portfolios of people who own ERNA. This list is generated using Robinhood data, and it’s not a recommendation.